PubRank

E C Böttger

Author PubWeight™ 246.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Res 1989 19.85
2 Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993 18.91
3 Detection and identification of mycobacteria by amplification of rRNA. J Clin Microbiol 1990 12.41
4 Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol 1993 9.76
5 Towards a phylogeny and definition of species at the molecular level within the genus Mycobacterium. Int J Syst Bacteriol 1990 7.65
6 Differentiation of Mycobacterium species by direct sequencing of amplified DNA. J Gen Microbiol 1990 7.33
7 Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol 1996 5.80
8 Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 1993 3.83
9 Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med 1993 3.75
10 Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 1994 3.28
11 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 2006 3.25
12 Elimination of contaminating DNA within polymerase chain reaction reagents: implications for a general approach to detection of uncultured pathogens. J Clin Microbiol 1993 3.22
13 Microheterogeneity within rRNA of Mycobacterium gordonae. J Clin Microbiol 1992 3.20
14 Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol 1999 3.16
15 Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996 2.92
16 Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol 1996 2.66
17 Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol 1995 2.50
18 rpsL+: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol 1995 2.49
19 Phylogenetic analysis and identification of different serovars of Mycobacterium intracellulare at the molecular level. FEMS Microbiol Lett 1990 2.47
20 Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol 2001 2.38
21 A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis 1998 2.34
22 Genetic heterogeneity within Mycobacterium fortuitum complex species: genotypic criteria for identification. J Clin Microbiol 1992 2.30
23 Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol 1997 2.24
24 Frequent contamination of Taq polymerase with DNA. Clin Chem 1990 2.23
25 Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob Agents Chemother 1994 2.23
26 Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene. J Clin Microbiol 1994 2.20
27 Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol 1998 2.19
28 Ribosomal DNA sequencing for identification of aerobic gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol 2003 2.02
29 Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol 1996 2.02
30 Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory. J Clin Microbiol 2004 1.96
31 Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study. J Clin Microbiol 1996 1.94
32 Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat Med 1998 1.94
33 Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol 1992 1.82
34 Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbiol 2001 1.79
35 Mycobacterium lentiflavum: an etiologic agent of cervical lymphadenitis. Clin Infect Dis 1997 1.79
36 Mycobacterium intermedium sp. nov. Int J Syst Bacteriol 1993 1.75
37 Transgenic mice selectively lacking MHC class II (I-E) antigen expression on B cells: an in vivo approach to investigate Ia gene function. Cell 1987 1.74
38 Mycobacterium interjectum, a new species isolated from a patient with chronic lymphadenitis. J Clin Microbiol 1993 1.73
39 Mycobacterium branderi sp. nov., a new potential human pathogen. Int J Syst Bacteriol 1995 1.71
40 Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol 2004 1.67
41 Introducing mutations into a chromosomal rRNA gene using a genetically modified eubacterial host with a single rRNA operon. Mol Microbiol 1996 1.65
42 Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations. Mol Microbiol 2002 1.64
43 Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae. J Clin Microbiol 1997 1.64
44 Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis 1996 1.61
45 Species-specific assessment of Mycobacterium leprae in skin biopsies by in situ hybridization and polymerase chain reaction. Lab Invest 1992 1.55
46 Lack of rifabutin resistance with prophylaxis for disseminated Mycobacterium avium complex. Lancet 1994 1.55
47 The role of ribosomal RNAs in macrolide resistance. Mol Microbiol 1997 1.53
48 A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov. J Clin Microbiol 1997 1.52
49 Mycobacterium tuberculosis nucleic acid probes for rapid diagnosis. Lancet 1993 1.51
50 Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1996 1.51
51 RecA-Mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob Agents Chemother 1999 1.51
52 Genetic interrelationships of proteolytic Clostridium botulinum types A, B, and F and other members of the Clostridium botulinum complex as revealed by small-subunit rRNA gene sequences. Antonie Van Leeuwenhoek 1994 1.50
53 Mycobacteriosis due to Mycobacterium genavense in six pet birds. J Clin Microbiol 1993 1.49
54 Mechanisms of streptomycin resistance: selection of mutations in the 16S rRNA gene conferring resistance. Antimicrob Agents Chemother 2001 1.46
55 Mycobacterium conspicuum sp. nov., a new species isolated from patients with disseminated infections. J Clin Microbiol 1995 1.41
56 Instability and site-specific excision of integration-proficient mycobacteriophage L5 plasmids: development of stably maintained integrative vectors. Int J Med Microbiol 2001 1.40
57 Recovery of mycobacteria from patients with cystic fibrosis. J Clin Microbiol 1999 1.37
58 Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts. J Clin Microbiol 2006 1.37
59 Cervical lymphadenitis in a child caused by a previously unknown mycobacterium. J Infect Dis 1993 1.35
60 Mutagenesis of 16S rRNA C1409-G1491 base-pair differentiates between 6'OH and 6'NH3+ aminoglycosides. J Mol Biol 2004 1.32
61 The 16S rRNA nucleotide sequence of Mycobacterium leprae: phylogenetic position and development of DNA probes. FEMS Microbiol Lett 1991 1.25
62 Mycobacterium confluentis sp. nov. Int J Syst Bacteriol 1992 1.23
63 Evaluation of the colorimetric VITEK 2 card for identification of gram-negative nonfermentative rods: comparison to 16S rRNA gene sequencing. J Clin Microbiol 2007 1.23
64 Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model. Infect Immun 2001 1.22
65 Role of 16S rRNA Helix 44 in Ribosomal Resistance to Hygromycin B. Antimicrob Agents Chemother 2003 1.22
66 Isolation of an unusual mycobacterium from an AIDS patient. J Clin Microbiol 1996 1.19
67 Cervical lymphadenitis due to an unusual mycobacterium. Eur J Clin Microbiol Infect Dis 1997 1.14
68 Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin Infect Dis 2001 1.14
69 A genetic model to investigate drug-target interactions at the ribosomal decoding site. Biochimie 2006 1.13
70 Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome. Eur J Clin Microbiol Infect Dis 1993 1.13
71 Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing. Antimicrob Agents Chemother 2012 1.12
72 The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines. Clin Microbiol Infect 2012 1.09
73 Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response. Eur J Immunol 1986 1.09
74 Investigation of mycobacterial recA function: protein introns in the RecA of pathogenic mycobacteria do not affect competency for homologous recombination. Mol Microbiol 1998 1.08
75 pKa of adenine 2451 in the ribosomal peptidyl transferase center remains elusive. RNA 2001 1.06
76 Detection and identification of Mycobacterium spp. in clinical specimens by combining the Roche Cobas Amplicor Mycobacterium tuberculosis assay with Mycobacterium genus detection and nucleic acid sequencing. J Clin Microbiol 2010 1.06
77 Infection with a novel, unidentified mycobacterium. N Engl J Med 1990 1.05
78 IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. J Biol Chem 1994 1.05
79 Etiological agents of mycobacterioses in pet birds between 1986 and 1995. J Clin Microbiol 1996 1.04
80 The gene encoding IFP 53/tryptophanyl-tRNA synthetase is regulated by the gamma-interferon activation factor. J Biol Chem 1993 1.04
81 Evaluation of conventional microbiological procedures and molecular genetic techniques for diagnosis of infections in patients with implanted orthopedic devices. J Clin Microbiol 2007 1.03
82 Cervical lymphadenitis caused by Mycobacterium celatum. Lancet 1994 1.03
83 Methods for the rapid identification of mycobacterial species. Clin Lab Med 1996 1.02
84 Bias of culture techniques for diagnosing mixed Mycobacterium genavense and Mycobacterium avium infection in AIDS. J Clin Microbiol 1994 1.02
85 Growth-deficient mycobacteria in patients with AIDS: diagnosis by analysis of DNA amplified from blood or tissue. Clin Infect Dis 1995 1.02
86 Mycobacterium genavense. Autopsy findings in three patients. Am J Clin Pathol 1994 1.01
87 Ribosomal drug resistance in mycobacteria. Res Microbiol 1996 1.01
88 Drug-resistant tuberculosis. Lancet 2001 1.00
89 An interferon-induced protein with release factor activity is a tryptophanyl-tRNA synthetase. FEBS Lett 1992 0.99
90 Molecular cloning and characterization of an interferon induced human cDNA with sequence homology to a mammalian peptide chain release factor. EMBO J 1992 0.99
91 Headaches for taxonomists: the M. avium-M. intracellulare complex. Int J Syst Bacteriol 1992 0.98
92 Development and evaluation of a molecular assay for detection of nontuberculous mycobacteria by use of the cobas amplicor platform. J Clin Microbiol 2008 0.96
93 Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma. J Invest Dermatol 1995 0.96
94 Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis. J Clin Microbiol 2011 0.95
95 Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods. J Clin Microbiol 1995 0.95
96 Qualitative and quantitative determination of enterobacterial common antigen (ECA) with monoclonal antibodies: expression of ECA by two Actinobacillus species. J Clin Microbiol 1987 0.95
97 The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs. J Immunol 1986 0.95
98 Improved decontamination method for recovering mycobacteria from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2002 0.94
99 Contribution of the multidrug efflux pump LfrA to innate mycobacterial drug resistance. FEMS Microbiol Lett 2000 0.94
100 Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J Immunol 1985 0.93
101 Guinea pigs with inherited deficiencies of complement components C2 or C4 have characteristics of immune complex disease. J Clin Invest 1986 0.92
102 Mycobacteria: genetics of resistance and implications for treatment. Chemotherapy 1999 0.91
103 Interferon-inducible Myc/STAT-interacting protein Nmi associates with IFP 35 into a high molecular mass complex and inhibits proteasome-mediated degradation of IFP 35. J Biol Chem 2000 0.90
104 Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae. Clin Microbiol Infect 2012 0.89
105 Transcriptional activation of psoriasis-associated cytokeratin K17 by interferon-gamma. Analysis of gamma-interferon activation sites. Eur J Biochem 1995 0.89
106 RGS1 is expressed in monocytes and acts as a GTPase-activating protein for G-protein-coupled chemoattractant receptors. J Biol Chem 1999 0.88
107 In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model. Clin Exp Immunol 1988 0.88
108 AIDS-related Mycobacterium kansasii infection with initial resistance to clarithromycin. Diagn Microbiol Infect Dis 1998 0.86
109 Inteins in mycobacterial GyrA are a taxonomic character. Microbiology 1998 0.85
110 Mycobacterium asiaticum as the probable causative agent in a case of olecranon bursitis. J Clin Microbiol 1995 0.85
111 Evaluation of the AID TB resistance line probe assay for rapid detection of genetic alterations associated with drug resistance in Mycobacterium tuberculosis strains. J Clin Microbiol 2014 0.83
112 Interferon-gamma regulates expression of a novel keratin class I gene. Eur J Immunol 1992 0.83
113 [Mycobacterium genavense infection in AIDS]. Dtsch Med Wochenschr 1993 0.83
114 Gene Replacement in Mycobacterium tuberculosis and Mycobacterium bovis BCG Using rpsL as a Dominant Negative Selectable Marker. Methods Mol Med 2001 0.83
115 Gene replacement in Mycobacterium smegmatis using a dominant negative selectable marker. Methods Mol Biol 1998 0.80
116 IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. J Immunol 1995 0.80
117 Evaluation of low dose anaphylatoxic peptides in the pathogenesis of the adult respiratory distress syndrome (ARDS). Monitoring of early C5a effects in a guinea-pig in vivo model after i.v. application. Eur J Clin Invest 1986 0.79
118 Transmission of multidrug-resistant tuberculosis in a low-incidence setting, Switzerland, 2006 to 2012. Euro Surveill 2014 0.79
119 In vivo splicing and functional characterization of Mycobacterium leprae RecA. J Bacteriol 2000 0.79
120 Depletion of tryptophan is not involved in expression of tryptophanyl-tRNA synthetase mediated by interferon. Infect Immun 1992 0.79
121 A cytoplasmic structure resembling large protein aggregates induced by interferons. J Histochem Cytochem 1999 0.78
122 Gen-Probe Rapid Diagnostic System for distinguishing between Mycobacterium avium and Mycobacterium paratuberculosis. J Clin Microbiol 1991 0.75
123 [Rapidity versus reliability: a critical analysis of the rapid diagnosis of mycobacterial infections with the polymerase chain reaction (PCR)]. Immun Infekt 1992 0.75
124 Prophylaxis of mycobacterial infection and acquired drug resistance. J Antimicrob Chemother 1997 0.75
125 Control of cytokeratin 17 expression by interferon gamma. Immunobiology 1995 0.75